Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseases
US9573996B2 · kind B2 · utility
5Cited by
23References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2012 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Dec 14, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A monoclonal secretory IgA antibody, which binds to and neutralizes a human proinflammatory cytokine or which binds to and blocks a human proinflammatory cytokine receptor. The secretory IgA antibody is useful in treating a variety of inflammatory diseases in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.